AFP and hepatocellular carcinoma: The results of this study confirm that a combination of morphologic features with AFP enables selection of HCC patients for liver transplantation, in line with numerous previous studies.6–10 The obtained results show that the addition of another biologic criterion represented by a complete response to neoadjuvant treatment not only does not improve the predictive efficacy of those models, but also is associated with their worse performance, a finding reported for the first time in the literature.